Researchers analyzed data from the FAERS to determine the prevalence of interstitial lung disease among patients with cancer receiving antibody-drug conjugates ...
Better diagnostics and more treatment options have modestly improved interstitial lung disease management in patients with ...
Researchers have found that patients with interstitial lung disease (ILD) are at greatly heightened risk of developing all ...
EULAR - The European Alliance of Associations for Rheumatology - has worked with the European Respiratory Society (ERS) to develop new clinical practice guidelines for interstitial lung disease (ILD) ...
ERS/EULAR guidelines outline best practices for diagnosis, monitoring, and treatment of connective tissue disease-related ILD ...
Machine learning model accurately diagnoses interstitial pneumonia, matching pulmonologist expertise and predicting mortality ...
Patients with acute exacerbations of idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF) face a high risk of morbidity and mortality and require careful, expert management, ...
Antifibrotic drugs like pirfenidone (Esbriet; Genentech) and nintedanib (Ofev; Boehringer Ingelheim) have been shown to be effective in patients with idiopathic pulmonary fibrosis (IPF) and in some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback